| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.632 | 13.730 | 25.385 | 19.167 | 18.085 | 15.792 | 14.307 | 5.685 | 0 | 0 |
| Total Income - EUR | 47.946 | 14.552 | 25.396 | 19.169 | 18.086 | 15.793 | 14.307 | 5.685 | 0 | 0 |
| Total Expenses - EUR | 32.218 | 10.351 | 15.128 | 11.645 | 11.157 | 11.459 | 14.250 | 9.203 | 33 | 0 |
| Gross Profit/Loss - EUR | 15.728 | 4.200 | 10.268 | 7.524 | 6.929 | 4.334 | 58 | -3.518 | -33 | 0 |
| Net Profit/Loss - EUR | 14.289 | 3.764 | 9.506 | 7.001 | 6.555 | 4.217 | -54 | -3.564 | -33 | 0 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Alsamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 46.105 | 24.119 | 29.877 | 23.134 | 26.827 | 6.257 | 7.293 | 3.309 | 3.267 | 3.248 |
| Inventories | 27 | 106 | 57 | 254 | 26 | 209 | 41 | 496 | 375 | 373 |
| Receivables | 17.263 | 19.289 | 17.931 | 19.138 | 18.601 | 2.332 | 5.081 | 2.811 | 2.811 | 1.790 |
| Cash | 28.815 | 4.724 | 11.889 | 3.742 | 8.200 | 3.716 | 2.171 | 2 | 81 | 1.086 |
| Shareholders Funds | 45.727 | 3.817 | 13.259 | 20.017 | 21.760 | 4.266 | 3.692 | 139 | 106 | 106 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 400 | 20.301 | 16.618 | 3.116 | 5.066 | 1.991 | 3.601 | 3.170 | 3.160 | 3.143 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Alsamed Srl